Related Experiment Videos
[Treatment of hypertension in elderly patients]
1Departement für Innere Medizin, Universitätsspital Zürich.
Insights
Treating hypertension in older adults, even isolated systolic hypertension, is recommended. Drug choice requires individualization based on coexisting conditions, with diuretics and beta-blockers showing proven cardiovascular risk reduction.
Area of Science:
- Geriatric Medicine
- Cardiology
- Pharmacology
Context:
- Hypertension management in the elderly is well-established, even for isolated systolic hypertension.
- Treatment decisions are significantly influenced by the presence of comorbidities.
- A wide range of antihypertensive medications are available, including diuretics, beta-blockers, calcium antagonists, and ACE-inhibitors.
Purpose:
- To review the indications and drug selection considerations for antihypertensive pharmacotherapy in elderly patients.
- To highlight the cardiovascular risk reduction achievable with pharmacotherapy in this population.
Summary:
- Pharmacotherapy can significantly reduce cardiovascular risk in elderly patients with hypertension.
- Diuretics and beta-blockers have demonstrated efficacy in reducing cardiovascular risk, particularly in isolated systolic hypertension.
- Emerging evidence suggests calcium antagonists may also offer comparable benefits.
Impact:
- Individualized pharmacotherapy based on comorbidities is crucial for effective hypertension management in older adults.
- Optimizing antihypertensive treatment in the elderly can lead to substantial reductions in cardiovascular events.
- Further research into the efficacy of calcium antagonists in elderly hypertension is warranted.
Abstract:
Today indications for treatment of hypertension in older age are no longer contested, even if only systolic pressure is raised. The choice of the antihypertensive drug for elderly patients, however, depends on concomitant diseases. The diversity of the latter demands a judicious, individualized use of the available substances (diuretics, beta-blockers, calcium antagonists and ACE-inhibitors). In elderly patients as well, a marked reduction of the cardiovascular risk is achievable by pharmacotherapy. So far, however, such results have only been reported for the use of diuretics and beta-blockers, in purely systolic hypertension by diuretics exclusively; however smaller studies, suggest that comparably favorable results may be obtained with calcium antagonists.